On Wed., April 6, FDA will hold a virtual meeting of its Vaccines and Related Biological Products Advisory Committee to discuss considerations for future COVID-19 vaccine booster doses and the strain selection process to address current and emerging variants during the Fall season 2022.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/iM5rEX6
No comments:
Post a Comment